Table 2.
Prevalence of IDF-defined metabolic syndrome and its components in sex and age groups
| IDF-defined metabolic syndrome | Obligate criterion | Additional criteria | |||||
| Central obesity1 | Hyper-triglyceridaemia2 | Low HDL chol-esterol3 | High blood pressure4 or medication use | High plasma glucose5 or type 2 diabetes | |||
| N | % (95% CI) | % | % | % | % | % | |
| Men | |||||||
| 20–29 yr | 808 | 11.0 (8.9 – 13.2) |
20.8 | 19.8 | 28.5 | 59.8 | 13.6 |
| 30–39 yr | 966 | 20.9 (18.3 – 23.5) |
34.1 | 29.9 | 27.4 | 58.5 | 22.8 |
| 40–49 yr | 1065 | 27.6 (24.9 – 30.3) |
40.9 | 38.7 | 30.9 | 69.4 | 28.8 |
| 50–59 yr | 848 | 32.7 (29.5 – 35.8) |
48.2 | 35.1 | 24.5 | 77.9 | 37.4 |
| 60–69 yr | 665 | 41.7 (37.9 – 45.4) |
55.2 | 37.0 | 26.9 | 87.1 | 46.9 |
| 70–79 yr | 569 | 44.8 (40.7 – 48.9) |
56.8 | 36.6 | 31.1 | 90.7 | 52.9 |
| 80–89 yr | 180 | 47.2 (39.9 – 54.5) |
62.2 | 40.0 | 31.1 | 93.3 | 57.2 |
| 20–89 yr | 5101 | 29.0 (27.7 – 30.2) |
42.0 | 33.3 | 28.3 | 72.8 | 32.7 |
| Women | |||||||
| 20–29 yr | 807 | 9.2 (7.2 – 11.2) |
30.5 | 7.6 | 28.4 | 21.8 | 8.6 |
| 30–39 yr | 877 | 14.1 (11.8 – 16.4) |
39.0 | 10.6 | 27.5 | 29.4 | 14.1 |
| 40–49 yr | 1014 | 21.8 (19.3 – 24.3) |
48.7 | 17.3 | 25.7 | 47.7 | 21.1 |
| 50–59 yr | 862 | 30.0 (27.0 – 33.1) |
56.5 | 22.5 | 21.3 | 70.5 | 30.2 |
| 60–69 yr | 645 | 49.0 (45.1 – 52.9) |
70.7 | 34.7 | 26.7 | 86.7 | 45.6 |
| 70–79 yr | 661 | 60.4 (56.6 – 64.1) |
77.8 | 40.5 | 31.3 | 94.1 | 52.6 |
| 80–89 yr | 239 | 64.4 (58.4 – 70.5) |
78.7 | 44.4 | 38.1 | 93.7 | 58.6 |
| 20–89 yr | 5105 | 30.3 (29.0 – 31.6) |
53.4 | 22.0 | 27.1 | 57.4 | 28.4 |
IDF, the International Diabetes Federation; HDL, high-density lipoprotein; CI, confidence interval.
1Waist circumference ≥94 cm in men, ≥80 cm in women.
2Triglycerides ≥1.7 mmol/L.
3HDL cholesterol <1.03 mmol/L in men, <1.29 mmol/L in women.
4Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg.
5Plasma glucose ≥5.6 mmol/L.